SmofKabiven peripheral

DRUG2 trials

Sponsors

JW Life Science, Fresenius Kabi

Conditions

ParentParenteral FeedingSurgery

Phase 3

A Safety, Efficacy Study of CombiflexOmega Peri Versus SmofKabiven Peripheral in Patients With Parenteral Nutrition

CompletedNCT01533298

JW Life ScienceParent

Start: 2011-07-31End: 2012-01-31Target: 50Updated: 2013-02-18

Efficacy and Safety of SmofKabiven Peripheral Versus Compounded Emulsion

CompletedNCT03792087

Fresenius KabiParenteral Feeding, Surgery

Start: 2017-12-21End: 2018-12-30Updated: 2021-08-02